Reported May 8, 2019 · Terminated

BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx…

Pacifico National, Inc. dba AmEx Pharmacy

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Pacifico National, Inc. dba AmEx Pharmacy · 1515 Elizabeth St Ste J · Melbourne, FL · 32901-3000

Is this the product you have?

  • BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne
  • FL 32901 Lot190212AB
  • BUD
    • 5/13/2019
    • Repackaged on 2/12/2019
Lot codes and dates
  • Lot190212AB
  • BUD5/13/2019
Amount recalled
249 syringes

Where it was sold

  • Nationwide

Why it was recalled

Defective Delivery System: difficult to express

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Pacifico National, Inc. dba AmEx Pharmacy recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Feb 16, 2021 · Data as of Sep 19, 5:55 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.